Evidence map›Paper›PMID 32245388›Full record

ArticleJournal of cardiothoracic surgery2020

Epicardial left atrial appendage occlusion with a new medical device: assessment of procedural feasibility, safety and efficacy in a large animal model.

Maximilian Y Emmert, Michael S Firstenberg, Arthur T Martella, Liming Lau, Stephen Zlock, Ashik Mohan, Taylor Spangler, Sarah Currie, Sacha P Salzberg, Etem Caliskan

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Surgical Methods and Devices for Atrial Fibrillation.Reviews in cardiovascular medicine · 2025
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Maximilian Y EmmertDepartment of Cardiovascular Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany. emmert@dhzb.de.
Michael S FirstenbergDepartment of Surgery, Summa Akron City Hospital, Akron, USA.
Arthur T MartellaOur Lady of Lourdes Medical Center, Camden, USA.
Liming LauGetinge Datascope Corp, Fairfield, USA.
Stephen ZlockGetinge Datascope Corp, Fairfield, USA.
Ashik MohanGetinge Datascope Corp, Fairfield, USA.
Taylor SpanglerPreclinical Medevice Innovations, San Carlos, USA.
Sarah CurriePreclinical Medevice Innovations, San Carlos, USA.
Sacha P SalzbergHeart Rhythm Center Zurich, Zurich, Switzerland.
Etem CaliskanDepartment of Cardiovascular Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEOur Lady of Lourdes Medical Center · USSumma Akron City Hospital · USZurich Heart House · CH

Funding

Getinge n/a
6 · The paper itself

Abstract

backgroundLeft atrial appendage occlusion (LAAO) represents a treatment alternative to anticoagulation in patients with atrial fibrillation. We evaluate a novel device for epicardial LAAO in a translational canine model.

methodsNine hounds (n = 9) were used to assess usability, safety, and efficacy of the TigerPaw Pro (TPP) device for epicardial LAAO. Following baseline imaging (intra-cardiac echocardiography (ICE) and angiography) and intraoperative visual inspection, usability was tested via a ``closure/re-opening`` maneuver followed by deployment of a total of twenty TPP devices (n = 20) on the left and right atrial appendages respectively. Procedural safety was evaluated by assessing for adverse-events via direct Epicardial inspection and endocardial imaging. Efficacy evaluation included assessment of device positioning, presence of residual stumps and completeness of closure. Post-mortem evaluation was performed to confirm safety and efficacy.

resultsUsability testing of all TPP devices was successful (n = 20;100%, delivery-time range 22-120 s) without any procedural adverse-events (tissue damage or tears, bleeding, vessel-impingement, structural impact). All devices fully traversed the ostium (n = 18) or appendage body (n = 2), and conformed smoothly to adjacent cardiac anatomy. In nineteen deployments (n = 19;95%), all device connector pairs were fully engaged, while in one TPP device the most distal pair remained unengaged. ICE and post-mortem inspections revealed complete closure of all appendage ostia (n = 18;100%) and only in one case a small residual stump was detected. Intraoperative safety findings were further confirmed post-mortem. Devices created a nearly smooth line of closure via symmetric endocardial tissue-coaptation.

conclusionsIn this preclinical model, the TPP demonstrated good ease of use for ostial access, ability to re-position (after engagement) and rapid deployment, while achieving safe and effective LAAO.

Indexed as

AnimalsAtrial AppendageAtrial FibrillationCardiac Surgical ProceduresDisease Models, AnimalDogsFeasibility StudiesFemaleMalePericardiumSurgical StaplingTreatment OutcomeAtrial fibrillationEpicardialLeft atrial appendage occlusionOral anticoagulationStrokeWarfarin

Identifiers

PMID32245388
PMCPMC7118967
OpenAlexW3014140931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.